Correction: MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1 von Venturutti, L., Russo, R. I. Cordo, Rivas, M. A., Mercogliano, M. F., Izzo, F., Oakley, R. H., Pereyra, M. G., De Martino, M., Proietti, C. J., Yankilevich, P., Roa, J. C., Guzmán, P., Cortese, E., Allemand, D. H., Huang, T. H., Charreau, E. H., Cidlowski, J. A., Schillaci, R., Elizalde, P. V.

Volltext

Correction: Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance von Russo, R. I. Cordo, Béguelin, W., Flaqué, M. C. Díaz, Proietti, C. J., Venturutti, L., Galigniana, N., Tkach, M., Guzmán, P., Roa, J. C., O’Brien, N. A., Charreau, E. H., Schillaci, R., Elizalde, P. V.

Volltext

Correction: Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis von Venturutti, L., Romero, L. V., Urtreger, A. J., Chervo, M. F., Russo, R. I. Cordo, Mercogliano, M. F., Inurrigarro, G., Pereyra, M. G., Proietti, C. J., Izzo, F., Díaz Flaqué, M. C., Sundblad, V., Roa, J. C., Guzmán, P., de Kier Joffé, E. D. Bal, Charreau, E. H., Schillaci, R., Elizalde, P. V.

Volltext

MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1 von Venturutti, L, Cordo Russo, R I, Rivas, M A, Mercogliano, M F, Izzo, F, Oakley, R H, Pereyra, M G, De Martino, M, Proietti, C J, Yankilevich, P, Roa, J C, Guzmán, P, Cortese, E, Allemand, D H, Huang, T H, Charreau, E H, Cidlowski, J A, Schillaci, R, Elizalde, P V

Volltext

Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis von Venturutti, L, Romero, L V, Urtreger, A J, Chervo, M F, Cordo Russo, R I, Mercogliano, M F, Inurrigarro, G, Pereyra, M G, Proietti, C J, Izzo, F, Díaz Flaqué, M C, Sundblad, V, Roa, J C, Guzmán, P, Bal de Kier Joffé, E D, Charreau, E H, Schillaci, R, Elizalde, P V

Volltext

Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation von SALATINO, M, BEGUELIN, W, ELIZALDE, P. V, PETERS, M. G, CARNEVALE, R, PROIETTI, C. J, GALIGNIANA, M. D, VEDOY, C. G, SCHILLACI, R, CHARREAU, E. H, SOGAYAR, M. C

Volltext

Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance von Cordo Russo, R I, Béguelin, W, Díaz Flaqué, M C, Proietti, C J, Venturutti, L, Galigniana, N, Tkach, M, Guzmán, P, Roa, J C, O'Brien, N A, Charreau, E H, Schillaci, R, Elizalde, P V

Volltext

Interactions between progestins and heregulin (HRG) signaling pathways : HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas von BALANA, M. E, LUPU, R, LABRIOLA, L, CHARREAU, E. H, ELIZALDE, P. V

Volltext

Nitric oxide inhibits Leydig cell steroidogenesis von Del Punta, K, Charreau, E H, Pignataro, O P

Volltext

Heregulin Induces Transcriptional Activation of the Progesterone Receptor by a Mechanism That Requires Functional ErbB-2 and Mitogen-Activated Protein Kinase Activation in Breast C... von Labriola, Leticia, Salatino, Mariana, Proietti, Cecilia J., Pecci, Adalí, Coso, Omar A., Kornblihtt, Alberto R., Charreau, Eduardo H., Elizalde, Patricia V.

Volltext

Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells von BALANA, Maria Eugenia, LABRIOLA, Leticia, SALATINO, Mariana, MOVSICHOFF, Federico, PETERS, Giselle, CHARREAU, Eduardo H, ELIZALDE, Patricia V

Volltext

Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p... von SALATINO, Mariana, SCHILLACI, Roxana, PROIETTI, Cecilia J, CARNEVALE, Romina, FRAHM, Isabel, MOLINOLO, Alfredo A, IRIBARREN, Adolfo, CHARREAU, Eduardo H, ELIZALDE, Patricia V

Volltext

Screening of FSH receptor gene in Argentine women with premature ovarian failure (POF) von Sundblad, Victoria, Chiauzzi, Violeta A, Escobar, Maria Eugenia, Dain, Liliana, Charreau, Eduardo H

Volltext

Nitric oxide inhibits Leydig cell steroidogenesis von Del Punta, K, Charreau, E H, Pignataro, O P

Volltext

Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice von PAZOS, P, LANARI, C, ELIZALDE, P, MONTECCHIA, F, CHARREAU, E. H, MOLINOLO, A. A

Volltext

Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures on an MPA-induced mammary adenocarcinoma von DRAN, G, LUTHY, I. A, MOLINOLO, A, MONTECCHIA, F, CHARREAU, E. H, PASQUALINI, C. D, LANARI, C

Volltext

Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas von Elizalde, Patricia V., Lanari, Claudia, Molinolo, Alfredo A., Guerra, Fabiana K., Balañá, Maria E., Simian, Marina, Iribarren, Adolfo M., Charreau, Eduardo H.

Volltext

Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors von MOLINOLO, A. A, LANARI, C, CHARREAU, E. H, SANJUAN, N, PASQUALINI, C. D

Volltext

Heregulin inhibits proliferation via ERKs and phosphatidyl‐inositol 3‐kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic... von Puricelli, Lydia, Proiettii, Cecilia J., Labriola, Leticia, Salatino, Mariana, Balañá, María E., Ghiso, Julio Aguirre, Lupu, Ruth, Pignataro, Omar P., Charreau, Eduardo H., Bal de Kier Joffé, Elisa, Elizalde, Patricia V.

Volltext

Seasonal Variations in Testicular LH, FSH, and PRL Receptors; in Vitro Testosterone Production; and Serum Testosterone Concentration in Adult Male Vizcacha (Lagostomus maximus maxi... von Fuentes, L.B., Calvo, J.C., Charreau, E.H., Guzmán, J.A.

Volltext